A searchable database of
medically documented cases

About the Project

Spontaneous Regression Together With Increased Calcification Of Incidental Meningioma.

Hirota et al., 2014Brain tumor

Hirota, K., Fujita, T., Akagawa, H., Onda, H., & Kasuya, H. (2014). spontaneous regression together with increased calcification of incidental meningioma. Surgical neurology international, 5, 73. https://doi.org/10.4103/2152-7806.132957

View Original Source →

Abstract

BACKGROUND: Regression of meningioma has been reported after hemorrhage or hormonal withdrawal. However, meningioma regression is rarely observed spontaneously. CASE DESCRIPTION: A right falx meningioma was incidentally diagnosed and was followed at every one-year by magnetic resonance imaging (MRI) for over 7 years. The tumor, with a maximum diameter of 4 cm, showed a slightly high density and was enhanced on computed tomography (CT), and a high intensity with a low-intensity core on T2 MRI, with significant edema. The meningioma gradually shrank together with a decrease of edema and increase of calcification. The initial volume, 25.5 cm(3), regressed linearly to less than half, 9.9 cm(3). CONCLUSION: Here, we report a case of an incidentally diagnosed meningioma that regressed spontaneously. The pattern of the regression was similar to that following gamma knife radiosurgery.

Case Details

Disease Location

Right falx meningioma

Personal Characteristics

66-year-old with medical history of HCV, dm2 on insulin.

Clinical Characteristics

Incidentally diagnosed meningioma a right falx meningioma with a maximum diameter of 4 cm showed a slightly high density and was enhanced on CT, and a high intensity with a low-intensity core on t2 MRI, with significant edema. The tumor was followed up with a yearly MRI.

Remission Characteristics

Follow up over 7 years showed complete regression

Treatment & Mechanisms

Proposed Remission Mechanisms

The tumor regression in the present patient may be due to the calcification of tumor cells promoted by a high glucose level.

Non-Clinical Treatment

None reported; insulin for dm2